Male extra vs vigrx plus

Male extra vs vigrx plus
The magic little blue pill, Viagra, has been a huge breakthrough for the love life of many men.
Many drugs that provide a major curative effect like this require a doctor's prescription. Sooner or
later, however, they seek a larger market by releasing a version that does not. The question is
whether this will ever occur with Viagra?
1998 was a huge year in erectile dysfunction treatments. It was the year Viagra came onto the
market and millions of men got back into the game as they say. Pfizer, the company behind the
amazing blue pill, was about as flush as a company can be. Then things started to change a bit as
one would expect in a capitalistic society. Other companies started coming out with similar
products. Before you know it, it was impossible to watch any television show that would remotely
cater to a male audience without seeing a few dozen commercials promoting erectile dysfunction
pills of one sort or another.
The problem with all these pills is they have a distribution bottleneck. All require that you consult
with a doctor before you can get "a boost" in your love life. Well, what if this wasn't the case? What
if you could simply buy a pill over the counter at the local drug store? That would certainly change
things and there have been continual rumors that Pfizer is considering doing this with Viagra.
https://medium.com/@binarycash/male-extra-review-does-this-suplements-really-workseedf9c530176
Will Viagra be available over the counter in the near future? The "Business" magazine in the UK
reported that Pfizer executives were discussing the idea as recently as late 2007. Given the fact two
years have passed since then with no announcement, one might assume that the idea has been
dropped. This is not necessarily the case. The primary issue is how to do you get the drug on the
market? The potency has to be reduced enough that the Federal Drug Administration will allow it to
be sold without a prescription, but still be potent enough to do the job for men. It is the ultimate
balancing act and one that Pfizer obviously has not figured out yet.